U01.17.002 Lynch syndrome (HNPCC) U01.17.002 Summary: Explore the molecular basis of Lynch Syndrome. Understand the "Second Hit" hypothesis, the characteristic proximal colon location, and associated extracolonic malignancies like endometrial cancer.

Lynch Syndrome: The DNA Mismatch Defect
#USMLEStep1 #MedEd #Pathology #LynchSyndrome #HNPCC #Genetics #Step1Prep #HighYield #MedSchool #Gastroenterology #Oncology #DNArepair #EndometrialCancer #FutureDoctor #StudyGram #MedTwitter #Anki #BoardExams #MedicalStudent #FirstAid #MedicalSchool #PreMed #Ph

NEW PODCAST: Want a practical #PBS recap of all the crucial updates for Australian oncology practice? Hit play on The PBS Update April 2026! Thanks to @craigunderhill.bsky.social for sharing his insights with us | Listen: t.ly/E_y9F + Spotify etc #PBSUpdate #Oncology #Cancer #Haematology #RareCancer

WATCH: Ranee Mehra, MD, highlights the importance of PD-L1 testing for head and neck cancer. #hncsm #oncology

Check out our head and neck cancer page for more expert insights!

www.onclive.com/clinical/hea...

Dr Flanagan on Coordinating Breast Cancer Treatment De-Escalation Strategies | OncLive Meghan R. Flanagan, MD, MPH, discusses the multidisciplinary complexities that arise when trying to coordinate de-escalated breast cancer care.

WATCH: Meghan R. Flanagan, MD, MPH, discusses the multidisciplinary complexities that arise when trying to coordinate de-escalated breast cancer care. @fredhutch.org @uwmedicine.bsky.social #MBCC26 #bcsm #oncology

www.onclive.com/view/dr-flan...

WATCH: Rena D. Callahan, MD, spotlights the future of triple-negative breast cancer management. @uclahealth.org #bcsm #oncology

Check out our breast cancer page for more expert insights!

www.onclive.com/clinical/bre...

Dr Flanagan on Debates About Genomic Assays for DCIS Treatment Decision-Making | OncLive Meghan R. Flanagan, MD, MPH, notes takeaways from a multidisciplinary tumor board discussion on how genomic assays can guide treatment decisions for DCIS.

Meghan R. Flanagan, MD, MPH, notes takeaways from a multidisciplinary tumor board discussion on how genomic assays can guide treatment decisions for DCIS. @fredhutch.org @uwmedicine.bsky.social #MBCC26 #bcsm #oncology

www.onclive.com/view/dr-flan...

🔬NEW study (RIKEN Center for Integrative Medical Sciences) links: #BRCA1 → #thyroidcancer and #BRCA2 → #bladdercancer, #skincancer, head & neck #cancer
A step toward extending #precisionmedicine beyond common cancers. #BRCA #Oncology #CancerResearch
www.linkedin.com/posts/drmelv...

Unpacking the Advantages and Limitations of Leading Frontline Regimens in EGFR-Mutated NSCLC | OncLive Susan Scott, MD, Julia Rotow, MD, and Enriqueta Felip, MD, PhD, debate the optimal choice of frontline regimen for EGFR-mutated NSCLC.

🧬 From osimertinib monotherapy to osimertinib + chemo and emerging regimens like amivantamab + lazertinib, clinicians now face key trade-offs in efficacy, toxicity, and sequencing.
Read more ➡️ www.onclive.com/view/unpacki...
#LungCancer #NSCLC #PrecisionOncology #TargetedTherapy #Oncology

Aaron Gerds, MD, MS, of Cleveland Clinic, breaks down the rationale for targeting CALR mutations and the drive for precision medicine approaches in MPNs #oncology

Watch more from the interview here: www.onclive.com/view/dr-gerd...

New: "Greater adherence to overall and healthy #plantbased diet patterns was associated with a lower risk of GC, whereas higher adherence to unhealthy plant-based patterns was associated with a higher risk." #gastriccancer #stomachcancer #oncology #cansky
onlinelibrary.wiley.com/doi/10.1002/...

FDA Grants Fast Track Designation to OPN-6602 for R/R Myeloma | OncLive OPN-6602 received FDA fast track designation for relapsed/refractory multiple myeloma after at least 4 prior lines of therapy.

🚀 The FDA has granted Fast Track designation to OPN-6602, an oral EP300/CBP inhibitor targeting novel transcriptional dependencies in heavily pretreated R/R multiple myeloma. 🧬
Read more ➡️ www.onclive.com/view/fda-gra...
#MultipleMyeloma #HemeOnc #ClinicalTrials #Oncology

Christian Capitini Named Director of the UW Carbone Cancer Center | OncLive Christian Capitini has been named the next director of the University of Wisconsin Carbone Cancer Center.

Christian Capitini has been named the next director of the University of Wisconsin Carbone Cancer Center. #oncology
www.onclive.com/view/christi...

This work reveals MIGs as safer, high-specificity therapeutic targets, advancing precision oncology and immunotherapy strategies.

#PKUResearch #Oncology

🔬 Rethinking #Cancer Vulnerabilities: Targeting What Tumors Cannot Lose

A team from #PekingUniversity Third Hospital, together with collaborators, explored genes that cancer cells cannot live without, known as mutation-intolerant genes (MIGs).

doi.org/10.1002/advs...

#PKUResearch #Oncology

#Bioinformatics supports #cancer research in various ways. To showcase some of these, our blog shares examples from real cancer research projects we have supported.
Read it now! ⬇️
www.fiosgenomics.com/bioinformatics-in-cancer...
#oncology

Nurses Urged to Avoid Age-Based Assumptions in Toxicity Care | Oncology Nursing News Eliya Shachar, UCLA Health, says toxicity risk is not independently tied to age or demographics, reinforcing consistent monitoring and individualized care for all patients.

In this video for Oncology Nursing News, Eliya Shachar, MD, discusses her research, which found that toxicity risk is not independently tied to age or demographics.

She highlights how #oncology nurses can apply these findings to support consistent monitoring.

www.oncnursingnews.com/view/nurses-...

Excited to be working alongside the incredible GlioBabes💫Power, resilience and honest conversations….to be revealed!🎙️🧩🧠 #braintumour #sexualwellbeing #braincancerawareness #intimacy #oncology

Kazia Therapeutics Appoints Dr. Sudha Rao as Chief Scientific Officer to Transform Oncology Research Kazia Therapeutics has appointed Dr. Sudha Rao as Chief Scientific Officer, enhancing its oncology platform focused on innovative cancer therapies.

Kazia Therapeutics Appoints Dr. Sudha Rao as Chief Scientific Officer to Transform Oncology Research #oncology #Australia #Sydney #Kazia_Therapeutics #Dr._Sudha_Rao

The Business Research Company - Market Research & Business Intelligence Leading market research and intelligence firm providing market research reports, consulting services, and data analytics to businesses worldwide.

Epkinly Market set for strong growth by 2030

Driven by rising lymphoma cases & targeted therapies. Bispecific antibody innovations are reshaping cancer treatment.

📊 Full report:
www.thebusinessresearchcompany.com/report/epkin...

#Oncology #Biotech

Join Beth Sandy, MSN, CRNP, FAPO, Jennifer Owens, MS, APRN, FNP-C & Eric K. Singhi, MD at a PeerView Live symposium on HER2-mutant NSCLC during #ONSCongress2026 ➡️ 5/15 at 6PM CDT | San Antonio + virtually: https://bit.ly/NSCLC-26-Sky #MedEd #Oncology

UKIO is aimed at the full #imaging & #oncology team, including those working in radiological sciences. Many of the 120+ sessions are multidisciplinary & the programme includes dedicated #physics sessions

View the full programme & book your place ukio.org.uk

New drug created at Northwestern helps pancreatic cancer patients live longer, oncologist says ABC7 talked to a widow who says the drug helped her have more time with her husband.

A new pancreatic cancer drug developed at Northwestern is offering real hope, with patients living longer in early reporting from the trial. Pancreatic cancer needs breakthroughs like this. #PancreaticCancer #CancerResearch #Oncology #TCSC
abc7chicago.com/post/new-pan...

Comprehensive genomic profiling in solid tumours: Navigating promise, challenges, and pathways to clinical integration The advent of high-throughput technologies has significantly enhanced our understanding of cancer biology. Genomic profiling methods, now widely and c…

Translating #CGP into tangible clinical benefit: in our new Review, we explore how landmark studies like the ROME trial have led this evolution.

Just out in Cancer Treatment Reviews 👇

www.sciencedirect.com/science/arti...

#Oncology #PrecisionMedicine

🚨 Last chance! Today is the final day to register for ESTRO 2026 Congress with the late registration fee⏳
Join the global oncology community, explore the latest advances in radiotherapy, and be part of the conversations shaping cancer care.
👉 https://bit.ly/4oT91tt

#ESTRO26 #Radiotherapy #Oncology

New in the may Issue:
Secondary causes of #diabetes: a crossroad of #endocrinology
and #oncology www.thelancet.com/journals/lan...
#diabetes #cancer

#MedSky #EndoSky #OncSky

#ewingsarcoma #ferroptosis | Poul Sorensen New immunotherapy article from the lab (https://lnkd.in/ePBcqqdi): I am very pleased to highlight our latest publication, “IL1RAP antibody-drug conjugates potently target primary and metastatic disea...

Glad to see this work now published. It was a great effort from the Advesya team and our collabortors at The University of British Columbia . 🔬🧬

#ADV101 #IL1RAP #DrugDevelopment #EwingSarcoma #oncology #ADC #PrecisionMedicine #AACR #CancerResearch #AML www.linkedin.com/posts/poul-s...

From Preclinical Hype to Clinical Reality: The eIO Landscape at #AACR26

ONCrg's AACR team has been diving deep into the emerging IO landscape, and the shifts between preclinical and clinical data are telling a fascinating story.

#Oncology #ImmunoOncology #DrugDevelopment #OncologyInsights

University of Maryland School of Medicine announces Greenebaum family's $5.5 million donation to advance cancer research and patient care at UMGCCC.

Photo of Michael Greenebaum in a suit jacket against a blurred autumn backdrop, paired with a message about legacy and cancer research commitment.

A $5.5M gift from the Marlene and Stewart Greenebaum Family Foundation will accelerate cancer research and care at UMGCCC—supporting innovations like CAR T‑cell therapy for solid tumors and expanding survivorship programs across Maryland.

#MedSky #MedEd #CancerResearch #Oncology #CancerCare

Cervical cancer remains one of the most preventable cancers—yet awareness and early action are key. 💙

#CervicalCancerAwareness #HPV #CancerPrevention #RadiationTherapy #HealthcareProfessionals #EarlyDetection #Oncology #PublicHealth #CancerCare #GART #RTT

1/13 🩺 CANCER CARE ENTERS A SCIENCE FICTION ERA 🩺

BBC's Jamie Ducharme reports on Maureen, whose tumour vanished in four months without chemo.

The secret? Unmasking cancer to the immune system.

#MedSky #Oncology #BioTech #CancerCare #Immunotherapy